Answers are grounded in this paper and cite their sources.
Developing new blood-contacting devices requires preclinical evaluation of their performance and safety, for which coagulation parameters are crucial. Thus, selecting the best animal model based on coagulation parameters is of utmost importance for extrapolating preclinical findings. Herein, we used thromboelastometry to compare human blood coagulation parameters with those of several animal species commonly used in preclinical evaluations. The influence of species, age, and sex were also investigated. Blood samples of humans and eight animal species (rats, rabbits, goats, sheep, dogs, pigs, and two species of monkeys) were analyzed using rotational thromboelastometry, and intrinsic (INTEM) and extrinsic (EXTEM) pathways of blood coagulation and fibrinogen activity (FIBTEM assay) were assessed. Clot firmness and clotting time of rabbits, pigs, and monkeys were similar to those of humans, whereas goats differed from humans in maximum clot firmness (EXTEM: 84 ± 2 mm vs. 62 ± 3 mm; FIBTEM: 41 ± 5 mm vs. 14 ± 2 mm). Dogs exhibited several differences, especially in clotting time, which was longer in dogs than humans in INTEM (233 ± 33 s vs. 201 ± 18 s), but shorter in dogs than humans in EXTEM (40 ± 8 s vs. 60 ± 6 s). Clotting time also varied among animal species, while age-related differences were primarily associated with clot firmness. Sex did not affect clotting time or clot firmness. Our findings provide useful insights for selecting the most appropriate animal model for preclinical research, which is critical to ensure reliability of preclinical data. Based on these findings, a new classification framework is proposed for selection of preclinical models.
No takes yet. Share an insight, caveat, or question.
Kimura et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: